Acknowledgement
Supported by : National Research Foundation of Korea (NRF), Seoul Women's University
References
- Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci 2017;18:1321. https://doi.org/10.3390/ijms18061321
- Feve B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2009;5:305-11. https://doi.org/10.1038/nrendo.2009.62
- Akash MS, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem 2018;119:105-10. https://doi.org/10.1002/jcb.26174
- Hemmingsen B, Gimenez-Perez G, Mauricio D, Roque I Figuls M, Metzendorf MI, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev 2017:CD003054.
- Lawson TB, Scott-Drechsel DE, Chivukula VK, Rugonyi S, Thornburg KL, Hinds MT. Hyperglycemia Alters the Structure and Hemodynamics of the Developing Embryonic Heart. J Cardiovasc Dev Dis 2018;5:E13. https://doi.org/10.3390/jcdd5010013
- Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism 2016;65:1049-61. https://doi.org/10.1016/j.metabol.2016.02.014
-
Lee EM, Lee YE, Lee E, Ryu GR, Ko SH, Moon SD, Song KH, Ahn YB. Protective effect of heme oxygenase-1 on high glucose-induced pancreatic
$\beta$ -cell injury. Diabetes Metab J 2011;35:469-79. https://doi.org/10.4093/dmj.2011.35.5.469 - Overman MJ, Pendleton N, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Rastrelli G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Lee DM, Correa ES, Ahern T, Laurent MR, Verschueren SM, Antonio L, Gielen E, Rutter MK, Vanderschueren D, Wu FC, Tournoy J; EMAS study group. Glycemia but not the metabolic syndrome is associated with cognitive decline: findings from the European Male Ageing Study. Am J Geriatr Psychiatry 2017;25:662-71. https://doi.org/10.1016/j.jagp.2017.02.004
- Dolan C, Glynn R, Griffin S, Conroy C, Loftus C, Wiehe PC, Healy ML, Lawlor B. Brain complications of diabetes mellitus: a cross-sectional study of awareness among individuals with diabetes and the general population in Ireland. Diabet Med 2018;35:871-9. https://doi.org/10.1111/dme.13639
- Wang CY, Neil DL, Home P. 2020 vision - an overview of prospects for diabetes management and prevention in the next decade. Diabetes Res Clin Pract 2018;143:101-12. https://doi.org/10.1016/j.diabres.2018.06.007
- Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimers Dement 2018;14:121-9. https://doi.org/10.1016/j.jalz.2017.10.009
- Weuve J, Hebert LE, Scherr PA, Evans DA. Prevalence of Alzheimer disease in US states. Epidemiology 2015;26:e4-6. https://doi.org/10.1097/EDE.0000000000000199
- Rojas-Carranza CA, Bustos-Cruz RH, Pino-Pinzon CJ, Ariza-Marquez YV, Gomez-Bello RM, Canadas-Garre M. Diabetes-related neurological implications and pharmacogenomics. Curr Pharm Des 2018;24:1695-710. https://doi.org/10.2174/1381612823666170317165350
- Pruzin JJ, Nelson PT, Abner EL, Arvanitakis Z. Review: relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol 2018;44:347-62. https://doi.org/10.1111/nan.12476
- Gaspar JM, Baptista FI, Macedo MP, Ambrosio AF. Inside the diabetic brain: role of different players involved in cognitive decline. ACS Chem Neurosci 2016;7:131-42. https://doi.org/10.1021/acschemneuro.5b00240
- Gonzalez-Reyes RE, Aliev G, Avila-Rodrigues M, Barreto GE. Alterations in glucose metabolism on cognition: a possible link between diabetes and dementia. Curr Pharm Des 2016;22:812-8. https://doi.org/10.2174/1381612822666151209152013
-
Macauley SL, Stanley M, Caesar EE, Yamada SA, Raichle ME, Perez R, Mahan TE, Sutphen CL, Holtzman DM. Hyperglycemia modulates extracellular amyloid-
$\beta$ concentrations and neuronal activity in vivo. J Clin Invest 2015;125:2463-7. https://doi.org/10.1172/JCI79742 - Kim DJ, Yu JH, Shin MS, Shin YW, Kim MS. Hyperglycemia reduces efficiency of brain networks in subjects with type 2 diabetes. PLoS One 2016;11:e0157268. https://doi.org/10.1371/journal.pone.0157268
- Rom S, Zuluaga-Ramirez V, Gajghate S, Seliga A, Winfield M, Heldt NA, Kolpakov MA, Bashkirova YV, Sabri AK, Persidsky Y. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. Forthcoming 2018.
- Silzer TK, Phillips NR. Etiology of type 2 diabetes and Alzheimer's disease: exploring the mitochondria. Mitochondrion. Forthcoming 2018.
- Reddy BR, Maitra S, Jhelum P, Kumar KP, Bagul PK, Kaur G, Banerjee SK, Kumar A, Chakravarty S. Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats. J Biosci 2016;41:407-17. https://doi.org/10.1007/s12038-016-9627-8
- Qin B, Xun P, Jacobs DR Jr, Zhu N, Daviglus ML, Reis JP, Steffen LM, Van Horn L, Sidney S, He K. Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Clin Nutr 2017;106:1032-40. https://doi.org/10.3945/ajcn.117.157834
- Kim EJ, Yang SJ. Nicotinamide reduces amyloid precursor protein and presenilin 1 in brain tissues of amyloid beta-tail vein injected mice. Clin Nutr Res 2017;6:130-5. https://doi.org/10.7762/cnr.2017.6.2.130
- Sawda C, Moussa C, Turner RS. Resveratrol for Alzheimer's disease. Ann N Y Acad Sci 2017;1403:142-9. https://doi.org/10.1111/nyas.13431
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;387:1513-30. https://doi.org/10.1016/S0140-6736(16)00618-8
- Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. London: Alzheimer's Disease International. Available from https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf [cited 2018 Sep 23]. 2015.
- Wu YT, Beiser AS, Breteler MM, Fratiglioni L, Helmer C, Hendrie HC, Honda H, Ikram MA, Langa KM, Lobo A, Matthews FE, Ohara T, Peres K, Qiu C, Seshadri S, Sjolund BM, Skoog I, Brayne C. The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol 2017;13:327-39.
-
Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE
${\varepsilon}4$ : the Cardiovascular Health Study Cognition Study. Arch Neurol 2008;65:89-93. - Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013;35:152-60. https://doi.org/10.1093/epirev/mxs012
- Ronnemaa E, Zethelius B, Sundelof J, Sundstrom J, Degerman-Gunnarsson M, Berne C, Lannfelt L, Kilander L. Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 2008;71:1065-71. https://doi.org/10.1212/01.wnl.0000310646.32212.3a
- Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, Sulkava R, Kivipelto M. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 2010;75:1195-202. https://doi.org/10.1212/WNL.0b013e3181f4d7f8
- Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res 1998;797:1-11. https://doi.org/10.1016/S0006-8993(98)00103-6
- Diggs-Andrews KA, Zhang X, Song Z, Daphna-Iken D, Routh VH, Fisher SJ. Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes 2010;59:2271-80. https://doi.org/10.2337/db10-0401
- Reno CM, Puente EC, Sheng Z, Daphna-Iken D, Bree AJ, Routh VH, Kahn BB, Fisher SJ. Brain GLUT4 knockout mice have impaired glucose tolerance, decreased insulin sensitivity, and impaired hypoglycemic counterregulation. Diabetes 2017;66:587-97. https://doi.org/10.2337/db16-0917
- Al Haj Ahmad RM, Al-Domi HA. Thinking about brain insulin resistance. Diabetes Metab Syndr 2018;12:1091-4. https://doi.org/10.1016/j.dsx.2018.05.003
- Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des 2003;9:795-800. https://doi.org/10.2174/1381612033455323
- Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes 2014;63:2232-43. https://doi.org/10.2337/db14-0568
- Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Allen AM, Mendelsohn FA. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 1987;121:1562-70. https://doi.org/10.1210/endo-121-4-1562
- Park CR, Seeley RJ, Craft S, Woods SC. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 2000;68:509-14. https://doi.org/10.1016/S0031-9384(99)00220-6
- Haj-ali V, Mohaddes G, Babri SH. Intracerebroventricular insulin improves spatial learning and memory in male Wistar rats. Behav Neurosci 2009;123:1309-14. https://doi.org/10.1037/a0017722
- Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 1996;17:123-30. https://doi.org/10.1016/0197-4580(95)02002-0
- Neth BJ, Craft S. Insulin resistance and Alzheimer's disease: bioenergetic linkages. Front Aging Neurosci 2017;9:345. https://doi.org/10.3389/fnagi.2017.00345
- Yoo DY, Yim HS, Jung HY, Nam SM, Kim JW, Choi JH, Seong JK, Yoon YS, Kim DW, Hwang IK. Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus. J Vet Med Sci 2016;78:957-62. https://doi.org/10.1292/jvms.15-0589
- Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease. Folia Neuropathol 2009;47:289-99.
-
Yang Y, Wu Y, Zhang S, Song W. High glucose promotes A
$\beta$ production by inhibiting APP degradation. PLoS One 2013;8:e69824. https://doi.org/10.1371/journal.pone.0069824 - Cao D, Lu H, Lewis TL, Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007;282:36275-82. https://doi.org/10.1074/jbc.M703561200
- Currais A, Prior M, Lo D, Jolivalt C, Schubert D, Maher P. Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice. Aging Cell 2012;11:1017-26. https://doi.org/10.1111/acel.12002
-
Devi L, Alldred MJ, Ginsberg SD, Ohno M. Mechanisms underlying insulin deficiency-induced acceleration of
$\beta$ -amyloidosis in a mouse model of Alzheimer's disease. PLoS One 2012;7:e32792. https://doi.org/10.1371/journal.pone.0032792 - Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 2004;18:902-4. https://doi.org/10.1096/fj.03-0978fje
- Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 2010;223:422-31. https://doi.org/10.1016/j.expneurol.2009.11.005
- Liu Y, Liu H, Yang J, Liu X, Lu S, Wen T, Xie L, Wang G. Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats. Neuroscience 2008;153:796-802. https://doi.org/10.1016/j.neuroscience.2008.03.019
- Mehla J, Chauhan BC, Chauhan NB. Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis 2014;39:145-62. https://doi.org/10.3233/JAD-131238
-
Vandal M, White PJ, Tremblay C, St-Amour I, Chevrier G, Emond V, Lefrancois D, Virgili J, Planel E, Giguere Y, Marette A, Calon F. Insulin reverses the high-fat diet-induced increase in brain A
$\beta$ and improves memory in an animal model of Alzheimer disease. Diabetes 2014;63:4291-301. https://doi.org/10.2337/db14-0375 - Wang JQ, Yin J, Song YF, Zhang L, Ren YX, Wang DG, Gao LP, Jing YH. Brain aging and AD-like pathology in streptozotocin-induced diabetic rats. J Diabetes Res 2014;2014:796840.
- Kursvietiene L, Staneviciene I, Mongirdiene A, Bernatoniene J. Multiplicity of effects and health benefits of resveratrol. Medicina (Kaunas) 2016;52:148-55. https://doi.org/10.1016/j.medici.2016.03.003
- Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005;280:37377-82. https://doi.org/10.1074/jbc.M508246200
-
Zhao HF, Li N, Wang Q, Cheng XJ, Li XM, Liu TT. Resveratrol decreases the insoluble A
$\beta$ 1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 2015;310:641-9. https://doi.org/10.1016/j.neuroscience.2015.10.006 - Hong JH, Lee H, Lee SR. Protective effect of resveratrol against neuronal damage following transient global cerebral ischemia in mice. J Nutr Biochem 2016;27:146-52. https://doi.org/10.1016/j.jnutbio.2015.08.029
- Tian X, Liu Y, Ren G, Yin L, Liang X, Geng T, Dang H, An R. Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity. Brain Res 2016;1650:1-9. https://doi.org/10.1016/j.brainres.2016.08.032
- Tian Z, Wang J, Xu M, Wang Y, Zhang M, Zhou Y. Resveratrol improves cognitive impairment by regulating apoptosis and synaptic plasticity in streptozotocin-induced diabetic rats. Cell Physiol Biochem 2016;40:1670-7. https://doi.org/10.1159/000453216
- Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Correa M, da Rosa MM, Rubin MA, Chitolina Schetinger MR, Morsch VM. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009;610:42-8. https://doi.org/10.1016/j.ejphar.2009.03.032
- Du LL, Xie JZ, Cheng XS, Li XH, Kong FL, Jiang X, Ma ZW, Wang JZ, Chen C, Zhou XW. Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi. Age (Dordr) 2014;36:613-23. https://doi.org/10.1007/s11357-013-9592-1
- Wong RH, Raederstorff D, Howe PR. Acute resveratrol consumption improves neurovascular coupling capacity in adults with type 2 diabetes mellitus. Nutrients 2016;8:E425. https://doi.org/10.3390/nu8070425
- Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Zachariah B. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: potential role of serine kinases. Chem Biol Interact 2016;244:187-94. https://doi.org/10.1016/j.cbi.2015.12.012
- Naijil G, Anju TR, Jayanarayanan S, Paulose CS. Curcumin pretreatment mediates antidiabetogenesis via functional regulation of adrenergic receptor subtypes in the pancreas of multiple low-dose streptozotocin-induced diabetic rats. Nutr Res 2015;35:823-33. https://doi.org/10.1016/j.nutres.2015.06.011
-
Thapa A, Jett SD, Chi EY. Curcumin attenuates amyloid-
$\beta$ aggregate toxicity and modulates amyloid-$\beta$ aggregation pathway. ACS Chem Neurosci 2016;7:56-68. https://doi.org/10.1021/acschemneuro.5b00214 - Huang HC, Zheng BW, Guo Y, Zhao J, Zhao JY, Ma XW, Jiang ZF. Antioxidative and neuroprotective effects of curcumin in an Alzheimer's disease rat model co-treated with intracerebroventricular streptozotocin and subcutaneous D-galactose. J Alzheimers Dis 2016;52:899-911. https://doi.org/10.3233/JAD-150872
- de Matos AM, de Macedo MP, Rauter AP. Bridging type 2 diabetes and Alzheimer's disease: assembling the puzzle pieces in the quest for the molecules with therapeutic and preventive potential. Med Res Rev 2018;38:261-324. https://doi.org/10.1002/med.21440
- Pistollato F, Iglesias RC, Ruiz R, Aparicio S, Crespo J, Lopez LD, Manna PP, Giampieri F, Battino M. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies. Pharmacol Res 2018;131:32-43. https://doi.org/10.1016/j.phrs.2018.03.012
- Marcason W. What are the components to the MIND diet? J Acad Nutr Diet 2015;115:1744. https://doi.org/10.1016/j.jand.2015.08.002
- Bae CS, Song J. The role of glucagon-like peptide 1 (GLP1) in type 3 diabetes: GLP-1 controls insulin resistance, neuroinflammation and neurogenesis in the brain. Int J Mol Sci 2017;18:E2493. https://doi.org/10.3390/ijms18112493
- de la Monte SM, Tong M, Wands JR. The 20-year voyage aboard the journal of Alzheimer's disease: docking at 'Type 3 Diabetes', environmental/exposure factors, pathogenic mechanisms, and potential treatments. J Alzheimers Dis 2018;62:1381-90. https://doi.org/10.3233/JAD-170829
Cited by
- In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes Mellitus vol.10, pp.None, 2018, https://doi.org/10.3389/fendo.2019.00634
- The Effects of Resveratrol in the Treatment of Metabolic Syndrome vol.20, pp.3, 2019, https://doi.org/10.3390/ijms20030535
- Metabolic Endotoxemia: A Potential Underlying Mechanism of the Relationship between Dietary Fat Intake and Risk for Cognitive Impairments in Humans? vol.11, pp.8, 2019, https://doi.org/10.3390/nu11081887
- The Alzheimer's Disease Exposome vol.15, pp.9, 2018, https://doi.org/10.1016/j.jalz.2019.06.3914
- Supplementation with Nicotinamide Riboside Reduces Brain Inflammation and Improves Cognitive Function in Diabetic Mice vol.20, pp.17, 2019, https://doi.org/10.3390/ijms20174196
- Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases vol.9, pp.3, 2018, https://doi.org/10.3390/jpm9030038
- Plant- and Nutraceutical-based Approach for the Management of Diabetes and its Neurological Complications: A Narrative Review vol.25, pp.33, 2018, https://doi.org/10.2174/1381612825666191014165633
- Advance of sporadic Alzheimer's disease animal models vol.40, pp.1, 2020, https://doi.org/10.1002/med.21624
- Dual Inhibition of DPP-4 and Cholinesterase Enzymes by the Phytoconstituents of the Ethanolic Extract of Prosopis cineraria Pods: Therapeutic Implications for the Treatment of Diabetes-associated Neur vol.16, pp.13, 2018, https://doi.org/10.2174/1567205016666191203161509
- A unified model of dementias and age‐related neurodegeneration vol.16, pp.2, 2018, https://doi.org/10.1002/alz.12012
- Cognitive impairments in type 2 diabetes, risk factors and preventive strategies vol.31, pp.2, 2020, https://doi.org/10.1515/jbcpp-2019-0105
- Cognitive impairments in type 2 diabetes, risk factors and preventive strategies vol.31, pp.2, 2020, https://doi.org/10.1515/jbcpp-2019-0105
- The Interplay between Diabetes and Alzheimer’s Disease—In the Hunt for Biomarkers vol.21, pp.8, 2018, https://doi.org/10.3390/ijms21082744
- Enzyme inhibitors from the aril of Myristica fragrans vol.130, pp.None, 2018, https://doi.org/10.1016/j.sajb.2019.12.020
- Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease vol.17, pp.5, 2020, https://doi.org/10.1021/acs.molpharmaceut.9b01227
- Prevalence and Incidence of Dementia in People with Diabetes Mellitus vol.75, pp.2, 2020, https://doi.org/10.3233/jad-191115
- Does hyperglycemia downregulate glucose transporters in the brain? vol.139, pp.None, 2020, https://doi.org/10.1016/j.mehy.2020.109614
- The Role of Nutrition in Individualized Alzheimer’s Risk Reduction vol.9, pp.2, 2018, https://doi.org/10.1007/s13668-020-00311-7
- Impaired cerebral autoregulation is associated with poststroke cognitive impairment vol.7, pp.7, 2018, https://doi.org/10.1002/acn3.51075
- Production of Liquid Milk Protein Concentrate with Antioxidant Capacity, Angiotensin Converting Enzyme Inhibitory Activity, Antibacterial Activity, and Hypoallergenic Property by Membrane Filtration a vol.8, pp.7, 2018, https://doi.org/10.3390/pr8070871
- A novel 3D-printed centrifugal ultrafiltration method reveals in vivo glycation of human serum albumin decreases its binding affinity for zinc vol.12, pp.7, 2018, https://doi.org/10.1039/d0mt00123f
- Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery vol.33, pp.3, 2018, https://doi.org/10.1089/ars.2020.8076
- Upregulation of AMPK Ameliorates Alzheimer’s Disease-Like Tau Pathology and Memory Impairment vol.57, pp.8, 2018, https://doi.org/10.1007/s12035-020-01955-w
- Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential vol.1866, pp.10, 2020, https://doi.org/10.1016/j.bbadis.2020.165858
- Citrus hystrix Extracts Protect Human Neuronal Cells against High Glucose-Induced Senescence vol.13, pp.10, 2018, https://doi.org/10.3390/ph13100283
- Diabeteskomplikationen - Diabetes und Nervensystem vol.145, pp.22, 2018, https://doi.org/10.1055/a-1038-0102
- Depression as a Risk Factor for Dementia and Alzheimer’s Disease vol.8, pp.11, 2020, https://doi.org/10.3390/biomedicines8110457
- Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer’s disease vol.17, pp.1, 2018, https://doi.org/10.1186/s12974-020-01956-5
- Lifestyle intervention to prevent Alzheimer’s disease vol.31, pp.8, 2018, https://doi.org/10.1515/revneuro-2020-0072
- Lifestyle intervention to prevent Alzheimer’s disease vol.31, pp.8, 2018, https://doi.org/10.1515/revneuro-2020-0072
- Comprehensive Review on Alzheimer’s Disease: Causes and Treatment vol.25, pp.24, 2018, https://doi.org/10.3390/molecules25245789
- Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches vol.8, pp.3, 2018, https://doi.org/10.3934/neuroscience.2021020
- Peripheral or nonperipheral tetra‐[4‐(9H‐carbazol‐9‐yl)phenoxy] substituted cobalt(II), manganese(III) phthalocyanines: Synthesis, acetylcholinesterase, butyrylcholineste vol.35, pp.1, 2018, https://doi.org/10.1002/aoc.6021
- Indole-3-acetamides: As Potential Antihyperglycemic and Antioxidant Agents; Synthesis, In Vitro α-Amylase Inhibitory Activity, Structure-Activity Relationship, and In Silico Studies vol.6, pp.3, 2021, https://doi.org/10.1021/acsomega.0c05581
- Palmitic Acid, but Not Lauric Acid, Induces Metabolic Inflammation, Mitochondrial Fragmentation, and a Drop in Mitochondrial Membrane Potential in Human Primary Myotubes vol.8, pp.None, 2018, https://doi.org/10.3389/fnut.2021.663838
- Boswellic Acids as Promising Leads in Drug Development against Alzheimer’s Disease vol.27, pp.1, 2021, https://doi.org/10.34172/ps.2020.25
- The Inhibition of Metabolic Inflammation by EPA Is Associated with Enhanced Mitochondrial Fusion and Insulin Signaling in Human Primary Myotubes vol.151, pp.4, 2018, https://doi.org/10.1093/jn/nxaa430
- Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease vol.22, pp.13, 2018, https://doi.org/10.3390/ijms22136656
- Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition vol.43, pp.None, 2018, https://doi.org/10.1016/j.redox.2021.102002
- Emerging Targets in Type 2 Diabetes and Diabetic Complications vol.8, pp.18, 2018, https://doi.org/10.1002/advs.202100275
- The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role? vol.11, pp.11, 2018, https://doi.org/10.3390/biom11111652
- Hearing difficulty is linked to Alzheimer’s disease by common genetic vulnerability, not shared genetic architecture vol.7, pp.1, 2021, https://doi.org/10.1038/s41514-021-00069-4
- The role of SLC transporters for brain health and disease vol.79, pp.1, 2018, https://doi.org/10.1007/s00018-021-04074-4
- The type 2 diabetes ‘modern preventable pandemic’ and replicable lessons from the COVID-19 crisis vol.25, pp.None, 2022, https://doi.org/10.1016/j.pmedr.2021.101636